ISPOR - HPR168 Lessons Learned From NOACs and CV Drugs That Have Launched in the EU5, US, JP and BR? An HTA Review and Evidence Generation Standpoint

Full Text

HPR168 Lessons Learned From NOACs and CV Drugs That Have Launched in the EU5, US, JP and BR? An HTA Review and Evidence Generation Standpoint

Abstract

Authors

B Yap E Sykes F Amadori A Makwana D Pruce

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now